dihexa safety concerns hgf c-met cancer risk Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Increased HGF Expression Induces Resistance
Increased HGF Expression Induces Resistance to c MET Tyrosine Kinase Inhibitors in Gastric Cancer Anticancer Research Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? Hepatocyte Growth Factor c Met Signaling in Head and Neck Cancer and Implications for Treatment
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19




